Goodwin Biotechnology, Inc.

Belkins
Goodwin Biotechnology, Inc. (GBI), based near Fort Lauderdale, Florida, is a fully integrated, customer-focused cGMP Contract Manufacturing Organization (CMO) of Biosimilar and innovative monoclonal antibodies, recombinant proteins, vaccines, Antibody Drug Conjugates (ADCs) and other bioconjugates.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

ACTICOR BIOTECH ANNOUNCES THE SUCCESS OF THE FIRST PHASE OF ITS ACTIMIS STUDY WITH GLENZOCIMAB IN PATIENTS WITH ACUTE ISCHEMIC STROKE

Acticor Biotech | October 05, 2020

news image

Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including acute ischemic stroke, today announced the completion of its ACTIMIS Dose Escalation Phase of Glenzocimab Study as add-on to standard of care in Patients with acute ischemic stroke. This Dose Escalation Phase was successfully completed with 60 patients enrolled from 6 European countries (France, Belgium, Germany, Spain, Switzerland and Italy). 5 cohorts of patients presenting wit...

Read More

CELL AND GENE THERAPY

BIOTECH STARTUP MEKONOS RAISES OVERSUBSCRIBED $25 MILLION ROUND TO OVERCOME PHARMA INDUSTRY'S CELL & GENE THERAPY DELIVERY HURDLES

Mekonos, Inc. | November 10, 2021

news image

Mekonos, a biotech company building the future of cell therapies on a chip, has raised $25M in an oversubscribed Series A round co-led by Reimagined Ventures, Fiscus Ventures, and PEAK6 Strategic Capital, a division of PEAK6 Investments. New institutional and strategic investors, including Section 32, Sands Capital, TDK Ventures, and the venture arm of Debiopharm, and previous investors, including Novartis Pharma AG (dRx Capital) and Elementum Ventures, also joined in the funding round that will...

Read More

MEDTECH

COSMOSID LAUNCHES ACCURATE AND EASY FUNCTIONAL MICROBIOME ANALYSIS WITH NEW SOFTWARE PLATFORM, COSMOSID-HUB: MICROBIOME

CosmosID | September 27, 2021

news image

A complete analysis of the microbiome should combine taxonomic profiling ("who is there?") with functional characterization ("what are they doing?") to discover the capabilities of an entire community of microorganisms. But research teams often require specialized training and extensive computational infrastructure to establish an in-house suite of tools for processing shotgun metagenomic data – and even with the right know-how, the processing can be both time-consuming...

Read More

MARINE BIOTECHNOLOGY MARKET 2020

Publicist 360 | April 08, 2020

news image

IndustryGrowthInsights, 08-04-2020: The research report on the Marine Biotechnology Market is a deep analysis of the market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. Experts have studied the historical data an...

Read More

Acticor Biotech | October 05, 2020

news image

ACTICOR BIOTECH ANNOUNCES THE SUCCESS OF THE FIRST PHASE OF ITS ACTIMIS STUDY WITH GLENZOCIMAB IN PATIENTS WITH ACUTE ISCHEMIC STROKE

Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including acute ischemic stroke, today announced the completion of its ACTIMIS Dose Escalation Phase of Glenzocimab Study as add-on to standard of care in Patients with acute ischemic stroke. This Dose Escalation Phase was successfully completed with 60 patients enrolled from 6 European countries (France, Belgium, Germany, Spain, Switzerland and Italy). 5 cohorts of patients presenting wit...

Read More

CELL AND GENE THERAPY

Mekonos, Inc. | November 10, 2021

news image

BIOTECH STARTUP MEKONOS RAISES OVERSUBSCRIBED $25 MILLION ROUND TO OVERCOME PHARMA INDUSTRY'S CELL & GENE THERAPY DELIVERY HURDLES

Mekonos, a biotech company building the future of cell therapies on a chip, has raised $25M in an oversubscribed Series A round co-led by Reimagined Ventures, Fiscus Ventures, and PEAK6 Strategic Capital, a division of PEAK6 Investments. New institutional and strategic investors, including Section 32, Sands Capital, TDK Ventures, and the venture arm of Debiopharm, and previous investors, including Novartis Pharma AG (dRx Capital) and Elementum Ventures, also joined in the funding round that will...

Read More

MEDTECH

CosmosID | September 27, 2021

news image

COSMOSID LAUNCHES ACCURATE AND EASY FUNCTIONAL MICROBIOME ANALYSIS WITH NEW SOFTWARE PLATFORM, COSMOSID-HUB: MICROBIOME

A complete analysis of the microbiome should combine taxonomic profiling ("who is there?") with functional characterization ("what are they doing?") to discover the capabilities of an entire community of microorganisms. But research teams often require specialized training and extensive computational infrastructure to establish an in-house suite of tools for processing shotgun metagenomic data – and even with the right know-how, the processing can be both time-consuming...

Read More

Publicist 360 | April 08, 2020

news image

MARINE BIOTECHNOLOGY MARKET 2020

IndustryGrowthInsights, 08-04-2020: The research report on the Marine Biotechnology Market is a deep analysis of the market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. Experts have studied the historical data an...

Read More